Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

Biorithm nominated for Top 20 in “Creating the New Normal” sector of Startup SG’s Slingshot Competition 2020

  • Published January 07, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Biorithm, a startup based in Singapore was awarded a spot in the Top 20 finalists of Startup SG’s Slingshot Competition’s “COVID-19 Challenge: Creating the New Normal” sector. In addition, they made it to the Top 100 Finalists overall, representing one of the Top 20 innovative startups in the MedTech, HealthTech & BioTech sector.

The Slingshot competition is an annual startup competition powered by Startup SG and organized by Enterprise Singapore. This year was its fourth annual edition, and due to the pandemic, the finals at SFF x SWITCH 2020 (Singapore FinTech Festival x Singapore Week of Innovation and Technology) were held virtually to accommodate its very global participants.

This year, the competition was also global and as a result, highly competitive. Biorithm competed with over 7,500 other innovative and globally based startups to receive its place in the Top 20 of two widely sought-out challenge sectors. The Top 100 start-ups were invited for a week of mentorship and pitch clinics, called Gear-Up, which prepared them for the three-day virtual finals.

Register Interest

[Pitch video from Slingshot]

About Biorithm

Biorithm provides innovative maternal-fetal connected care solution to improve pregnancy outcomes for patients and healthcare providers.

Forging new frontiers in pregnancy care, Biorithm has developed cutting edge analytic software together with medical-grade abdominal ECG wearable designed for remote monitoring of maternal & fetal physiological parameters.

Our unique solution allows accurate monitoring of a wide range of vital pregnancy data, empowering patient and clinicians to identify early signs of maternal-fetal complication for timely intervention while reducing the cost of care.

Founded by doctors and engineers, Biorithm is a medical technology start-up spun-off from Nanyang Technological University in Singapore. We believe that comprehensive maternal healthcare should leverage the power of digital health and advanced sensors to address individual patient and clinicians needs, enhance data-driven decisions, complication prevention, and provide access to affordable and preventive care.

Register Interest

Capital Insights
Navigating the Market Inflection Point: Exclusive Investor & Founder Meetups Across Australia

The market is at a genuine inflection point in mid-2025, with conflicting signals from AI breakthroughs and geopolitical shifts. This blog announces exclusive, intimate investor and founder meetups across Australia, designed to cut through the noise, reveal unfiltered truths about the H2 2025 outlook, and map the “smart money migration” to position participants for strategic advantage.

Capital Insights
Beyond the Hype: Strategic Digital Asset Investing for a New Financial Era

The financial world is undergoing a profound transformation driven by Digital Assets. Learn why hundreds of billions are pouring into new digital infrastructure, with stablecoins now outperforming Mastercard/Visa in transaction volume. This article guides investors beyond the hype to strategic digital asset investing, exploring yield, DePIN, DeFi, and AI+Blockchain for the new financial era. Discover more at Venture & Capital SYDNEY 2025.

Join over 45,000+ sophisticated investors

Join Now